{"disease":{"id":"macular-degeneration-age-related","name":"macular degeneration age related"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05593913","title":"Clinical Evaluation of VeriSee AMD in Screening for Age-Related Macular Degeneration","phase":"","overall_status":"COMPLETED","enrollment_count":986,"lead_sponsor_name":"Acer Medical Inc.","has_results":true},{"nct_id":"NCT07440225","title":"A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":960,"lead_sponsor_name":"EyeBiotech Ltd.","has_results":false},{"nct_id":"NCT07496567","title":"A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":960,"lead_sponsor_name":"EyeBiotech Ltd.","has_results":false},{"nct_id":"NCT04723160","title":"Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph","phase":"","overall_status":"COMPLETED","enrollment_count":748,"lead_sponsor_name":"Visionary Intelligence Ltd.","has_results":false},{"nct_id":"NCT04480463","title":"A Study to Comparing SCD411 and Eylea® in Subjects With Wet Age-related Macular Degeneration (AMD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":576,"lead_sponsor_name":"Sam Chun Dang Pharm. Co. Ltd.","has_results":true},{"nct_id":"NCT06190093","title":"A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects with Neovascular Age-related Macular Degeneration (AMD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Outlook Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03972709","title":"A Study Assessing the Safety, Tolerability, and Efficacy of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":372,"lead_sponsor_name":"Genentech, Inc.","has_results":true},{"nct_id":"NCT03834753","title":"A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":228,"lead_sponsor_name":"Outlook Therapeutics, Inc.","has_results":false},{"nct_id":"NCT06717139","title":"Recurrence and Predictive OCT Biomarkers in Quiescent Neovascular AMD","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":220,"lead_sponsor_name":"St. Erik Eye Hospital","has_results":false},{"nct_id":"NCT06722157","title":"A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":202,"lead_sponsor_name":"Boehringer Ingelheim","has_results":false},{"nct_id":"NCT04516278","title":"A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":195,"lead_sponsor_name":"Outlook Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05587062","title":"Efficacy and Safety of Aflibercept in Patients With Neovascular Age-related Macular Degeneration","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"Cinnagen","has_results":false},{"nct_id":"NCT02348359","title":"X-82 to Treat Age-related Macular Degeneration","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":157,"lead_sponsor_name":"Tyrogenex","has_results":true},{"nct_id":"NCT04607148","title":"A Study Assessing the Long-Term Safety and Tolerability of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":144,"lead_sponsor_name":"Genentech, Inc.","has_results":true},{"nct_id":"NCT06662162","title":"Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"i-Lumen Scientific AUS PTY LTD","has_results":false},{"nct_id":"NCT05637255","title":"A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular Age-related Macular Degeneration (AMD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"Sylentis, S.A.","has_results":false},{"nct_id":"NCT05447650","title":"Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT)","phase":"NA","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"i-Lumen Scientific, Inc.","has_results":false},{"nct_id":"NCT03418220","title":"Comparison of Cytokine Profiles in Aqueous Humor of Patients With Age Related Macular Degeneration (AMD)","phase":"NA","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT05677685","title":"VISUPRIME® Eye Drops","phase":"NA","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"VISUfarma SpA","has_results":false},{"nct_id":"NCT02875704","title":"Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy","phase":"","overall_status":"TERMINATED","enrollment_count":77,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT03038880","title":"Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":76,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT04642183","title":"Single In-Clinic Encounter With the Notal Vision Home OCT","phase":"","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Notal Vision Inc.","has_results":false},{"nct_id":"NCT05961332","title":"COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy","phase":"NA","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"University of Wisconsin, Madison","has_results":false},{"nct_id":"NCT03423823","title":"Ziv-aflibercept Efficacy in Better Regulating AMD","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Kapil Kapoor","has_results":false},{"nct_id":"NCT03844074","title":"A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Outlook Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04832724","title":"RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT07235527","title":"Real-Life Clinical Outcomes of Aflibercept Biosimilar MY-1701P in the Treatment of Exudative Age-Related Macular Degeneration","phase":"","overall_status":"RECRUITING","enrollment_count":54,"lead_sponsor_name":"Saglik Bilimleri Universitesi","has_results":false},{"nct_id":"NCT04504123","title":"MMP-9 Inhibition for Recalcitrant Wet AMD","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"University of Iowa","has_results":false},{"nct_id":"NCT03066258","title":"Safety and Tolerability of RGX-314 (Investigational Product) Gene Therapy for Neovascular AMD Trial","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"REGENXBIO Inc.","has_results":true},{"nct_id":"NCT05988827","title":"Effect of Minimizing Light Exposure Intensity on Macular Function After Cataract Surgery in Patients With Early or Intermediate AMD","phase":"NA","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Elsan","has_results":false},{"nct_id":"NCT02225119","title":"The Focal Electro-Oculogram in Macular Disease","phase":"","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT06582511","title":"Evaluating Metabolic Changes Induced by PhotoBioModulation Through Spectrally Resolved Autofluorescence in Dry Age-Related Macular Degeneration Patients","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Francesco Bandello","has_results":false},{"nct_id":"NCT03748784","title":"ADVM-022 Intravitreal Gene Therapy for Wet AMD","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Adverum Biotechnologies, Inc.","has_results":false},{"nct_id":"NCT04645212","title":"Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":23,"lead_sponsor_name":"Adverum Biotechnologies, Inc.","has_results":false},{"nct_id":"NCT07255885","title":"CRYSTALSIGHT: ''Cohort 1.5\" Clinical Investigation Study With OCCUTRACK and Tan Tock Seng Eye Clinic to Further Develop Remote Monitoring of Maculopathy at Home Using Artificial Intelligence for Eye Tracking","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Tan Tock Seng Hospital","has_results":false},{"nct_id":"NCT02571972","title":"Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Wills Eye","has_results":true},{"nct_id":"NCT06888492","title":"To Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD)","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":8,"lead_sponsor_name":"Guangzhou Jiayin Biotech Ltd","has_results":false},{"nct_id":"NCT03699618","title":"Anti-VEGF Therapy for Subfoveal Hemorrhage in Patients With Neovascular Age-Related Macular Degeneration","phase":"","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT06398080","title":"An Observational Study to Investigate the Use of Aflibercept 8 mg to Treat Adult Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) in a Real-World Setting","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false}],"total":39},"guidelines":[],"source":"Drug Landscape verified database"}